πŸ•ŠοΈ PEACE Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference
βš™οΈ influence of #ECLS circuit & components
πŸ’‰ anticoagulant medications
🎯 monitoring & targets
πŸ§ͺ monitoring & replacement of AT, fibrinogen, vWF
πŸ’‰ antifibrinolytic & adjunct hemostatic agents
πŸ”ͺ perioperative period
🩸 bleeding & thrombotic complications
πŸ” priorities for clinical Research
#FOAMcc #FOAMecmo #PedsICU
Summary πŸ”“ https://bit.ly/3RU7l5c
& special issue πŸ”“ https://bit.ly/3XVOqL7
Investigating/characterizing platelet & leukocyte adsorption in #ECMO circuits
πŸ’‘detailed protocol utilizing immunofluorescence to help extend knowledge in binding mechanisms + pathophysiology of adsorption, providing guidance for better circuit design. Protocol enabling comprehensive characterization of cellular binding to circuits collected from patients, could also be adapted to circuit binding studies of other #ECLS systems, such as #CPB, #VAD, #RRT devices.
πŸ–‡οΈ https://bit.ly/3XK4oYD
Acquired von Willebrand syndrome in #ECMO support, review of current evidence
πŸ” prevalence of AVWS in #ECLS children & adults
🩸 bleeding complications in AVWS
βš™οΈ management
πŸ’‰ desmopressin & VWF-containing concentrates.
πŸ›‘ inhibition of ADAMTS-13-mediated proteolysis of VWF
Limited evidence & need for a consensus definition, but data suggest almost all pts develop partial/complete loss of VWF HMW multimers within hours since initiation; weaning completely resolves AVWS.
πŸ–‡οΈ https://bit.ly/3RK3OGp
Thrombolysis before VA #ECMO cannulation in high-risk pulmonary embolism
πŸ” 72 high-risk PE pts; 43% underwent pre-ECMO thrombolysis
🩸incidence of moderate-to-severe bleeding notably elevated in both groups
πŸͺ¦ no difference in 90-day survival if systemic thrombolysis or not
πŸ—“οΈ long-term QoL acceptable; no chronic thromboembolic pulmonary hypertension
Recent systemic thrombolysis, as a single parameter, should not be considered contraindication for #ECLS in this population
πŸ”“ https://rdcu.be/dLOBk
Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort study

πŸ“’ The June 2024 ELSO newsletter is out! DoN'T miss:
πŸ–‹οΈ Message from our President, Graeme MacLaren
πŸ› Bedside with Dr Bartlett: why we have gas blender in the sweep gas?? Answer is different for VV & VA #ECMO
πŸŽ“ ELSO Academy: the Neonatal & Pediatric Foundations training course
🌏 #ECLS around the world, updates from ELSO Chapters including next annual meetings & conferences
πŸ“ƒ News from ELSO Committees
πŸ–‹οΈ CEO Christine Stead remarks & more! Read all on ELSO website at
πŸ”— bit.ly/2IR8RCl
Mechanical circulatory support in cardiogenic shock:
πŸ›οΈ VA #ECMO to be consigned to the museum? NO: systematic use of #ECLS in AMICS not supported, but is useful as optimal therapies fail
πŸ” available evidence & need for: real benefit of ECMO difficult to show in RCTs, especially as will likely continue to be used as rescue strategy
πŸͺ‘ personalize management! Both VA-ECMO & MFP have a role in severe CS: select most appropriate #MCS for the specific patient
πŸ”“ https://rdcu.be/dLt6T
Mechanical circulatory support in cardiogenic shock: microaxial flow pumps for all and VA-ECMO consigned to the museum? | Critical Care

Consumptive coagulopathy during #ECLS
πŸ”Ž close monitoring & follow up pivotal during the #ECMO run
⛔️ giving platelets/clotting factors to fix numbers often worsens underlying process
🩸 low doses of anticoagulants may protect both circuit (vs thrombotic complications) & patient (vs bleeding & thrombosis)
⛔️ bleeding complications should NOT always prompt complete cessation of UFH
Detailed underlying pathophysiological process & physiological rationale free to read #FOAMcc
πŸ”“ https://rdcu.be/dLmXO
Consumptive coagulopathy: how low-dose unfractionated heparin can prevent bleeding complications during extracorporeal life support

Beyond VA & VV #ECMO, novel, alternative cannulation strategies to address unique factors related to individual cases when traditional configuration are not enough...
🫁 parallel VV circuits: to provide higher EBF/CO2 clearance in patients with ARDS with high CO & VO2
πŸ«πŸ«€veno-venopulmonary #ECLS: added benefit of RV support
πŸ«€ LAVA ECMO: biventricular support with biatrial unloading
πŸ«€ LV apical insertion of dual-lumen cannula if significant peripheral vascular disease
πŸ–‡οΈ https://bit.ly/3zk1O0Y
πŸ“’ Unmissable opportunity if you want to learn everything about VV (dual site + bicaval-dual lumen) & VA #ECLS cannulation πŸ“’
Some (few) spots still available for ELSO #ECMO Cannulation Workshop on June 23!
A hands-on event aimed to learn how to safely perform percutaneous cannulation with a team of international experts... Register NOW ‼️
πŸ”— https://bit.ly/3sUQcPq
πŸŽ“ Adult #cannulation workshop
πŸ—ΊοΈ ELSO Headquarters, Ann Arbor MI
πŸ—“οΈ June 23 2024 (1 one day session)
πŸ“« [email protected]
ELSO Courses & Workshops | ECMO | ECLS

πŸ” For #ECPR as for all patients keep on caring & keep on analyzing! Initial lactate can indicate higher burden of ischemia prior to #ECMO, with subsequent clearance determined by relationship between lactate catabolism vs generation. Neurologic survival advantage if adequate #extracorporeal BF/catabolic function & no longer ischemia. Pts who fail to rapidly clear lactate warrant evaluation for: ongoing ischemia or insufficient #ECLS
πŸ–‡οΈ https://bit.ly/3KGs2xo

Refers to
πŸ”“ https://bit.ly/3x997bt